This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Xu RH , Cohen M , Tang Y , Lazear E , Whitbeck JC , Eisenberg RJ , Cohen GH , Sigal LJ
The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination
J Exp Med. 2008 Apr 14;205(4) :981-92
AbstractNonliving antiviral vaccines traditionally target proteins expressed at the surface of the virion with the hope of inducing neutralizing antibodies. Orthopoxviruses (OPVs), such as the human smallpox virus and the mouse-equivalent ectromelia virus (ECTV; an agent of mousepox), encode immune response modifiers (IRMs) that can increase virulence by decreasing the host immune response. We show that one of these IRMs, the type I interferon (IFN) binding protein (bp) of ECTV, is essential for ECTV virulence and is a natural target of the antibody response. More strikingly, we demonstrate that immunization with recombinant type I IFN bp protects mice from lethal mousepox. Collectively, our experiments have important implications for our understanding of the role of IRMs in OPV virulence and of type I IFNs in OPV infections. Furthermore, our work provides proof of concept that effective antiviral vaccines can be made to prevent disease by targeting virulence factors as an alternative to the traditional approach that attempts to prevent infection by virus neutralization.
NotesXu, Ren-Huan Cohen, Matthew Tang, Yong Lazear, Eric Whitbeck, J Charles Eisenberg, Roselyn J Cohen, Gary H Sigal, Luis J AI065544/AI/United States NIAID CA006927/CA/United States NCI U54-AI57168/AI/United States NIAID Research Support, N.I.H., Extramural United States The Journal of experimental medicine J Exp Med. 2008 Apr 14;205(4):981-92. Epub 2008 Apr 7.